» Articles » PMID: 38126664

Computational Simulation of JAK/STAT Signaling in Somatic Versus Germline Stem Cells

Overview
Journal Dev Dyn
Publisher Wiley
Date 2023 Dec 21
PMID 38126664
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway regulates a variety of cellular processes. A major activation event in this pathway involves the phosphorylation of a tyrosine of STAT, converting unphosphorylated STAT (uSTAT) to phosphorylated STAT (pSTAT), an active transcription factor. In a noncanonical role, uSTAT contributes to the maintenance of heterochromatin stability. As such, an increase in pSTAT concurrently reduces uSTAT, resulting in heterochromatin loss, as observed in Drosophila somatic tissues. Paradoxically, an opposing phenomenon occurs in Drosophila male germline stem cells (GSCs), where the JAK/STAT pathway remains persistently active due to a continuous supply of ligands. Here, computational simulations were employed to dissect JAK/STAT pathway activation under different cellular contexts, mimicking somatic and germline cells. In these simulations, ordinary differential equations were leveraged to replicate the chemical reactions governing JAK/STAT signaling under different conditions.

Results: The outcomes indicate that transient ligand stimulation, typical in somatic tissues, led to a momentary reduction in uSTAT levels. Conversely, sustained ligand stimulation, a characteristic feature of the GSC niche, resulted in elevated uSTAT levels at equilibrium.

Conclusion: The simulation suggests that the duration of ligand exposure could explain the observed opposite effects of JAK/STAT activation on heterochromatin in somatic versus GSCs.

Citing Articles

GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT3.

Chen Z, Xu L, Lin S, Huang H, Long Q, Liu J Cancer Biol Ther. 2024; 25(1):2420383.

PMID: 39487760 PMC: 11540090. DOI: 10.1080/15384047.2024.2420383.

References
1.
Harrison D, Binari R, Nahreini T, Gilman M, Perrimon N . Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 1995; 14(12):2857-65. PMC: 398404. DOI: 10.1002/j.1460-2075.1995.tb07285.x. View

2.
Betz A, Lampen N, Martinek S, YOUNG M, Darnell Jr J . A Drosophila PIAS homologue negatively regulates stat92E. Proc Natl Acad Sci U S A. 2001; 98(17):9563-8. PMC: 55492. DOI: 10.1073/pnas.171302098. View

3.
Morrison S, Spradling A . Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008; 132(4):598-611. PMC: 4505728. DOI: 10.1016/j.cell.2008.01.038. View

4.
Dawson M, Bannister A, Gottgens B, Foster S, Bartke T, Green A . JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature. 2009; 461(7265):819-22. PMC: 3785147. DOI: 10.1038/nature08448. View

5.
Griffiths D, Li J, Dawson M, Trotter M, Cheng Y, Smith A . LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease. Nat Cell Biol. 2010; 13(1):13-21. PMC: 3008749. DOI: 10.1038/ncb2135. View